 | • レポートコード：MRC2-11QY05116 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は女性健康治療のグローバル市場について調査・分析したレポートです。種類別（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん）市場規模、用途別（診断および画像センター、病院および診療所、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別女性健康治療の競争状況、市場シェア ・世界の女性健康治療市場：種類別市場規模 2015年-2020年（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん） ・世界の女性健康治療市場：種類別市場規模予測 2021年-2026年（閉経、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、不妊症、婦人科がん） ・世界の女性健康治療市場：用途別市場規模 2015年-2020年（診断および画像センター、病院および診療所、在宅ケア） ・世界の女性健康治療市場：用途別市場規模予測 2021年-2026年（診断および画像センター、病院および診療所、在宅ケア） ・北米の女性健康治療市場分析：米国、カナダ ・ヨーロッパの女性健康治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの女性健康治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の女性健康治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの女性健康治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Abbott、Pfizer、Eli Lilly、Bayer、Merck、Roche、Novo Nordisk、Oasmia、Sanofi、Takeda、Allergan ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Women’s experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.
Rise in cases of infertility and increasing incidences of chronic disorders among women are seen as the key forces driving the growth of the global market.
Market Analysis and Insights: Global Women Health Therapeutics Market
The global Women Health Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Women Health Therapeutics Scope and Market Size
Women Health Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Women Health Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Abbott
Pfizer
Eli Lilly
Bayer
Merck
Roche
Novo Nordisk
Oasmia
Sanofi
Takeda
Allergan
Market segment by Type, the product can be split into
Menopause
Endometriosis
Postmenopausal osteoporosis
Breast cancer
Polycystic ovary syndrome
Infertility
Gynecological cancer
Market segment by Application, split into
Diagnostic and imaging centers
Hospitals and clinics
Home care
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Women Health Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Women Health Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Menopause
1.4.3 Endometriosis
1.4.4 Postmenopausal osteoporosis
1.4.5 Breast cancer
1.4.6 Polycystic ovary syndrome
1.4.7 Infertility
1.4.8 Gynecological cancer
1.5 Market by Application
1.5.1 Global Women Health Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic and imaging centers
1.5.3 Hospitals and clinics
1.5.4 Home care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Women Health Therapeutics Market Perspective (2015-2026)
2.2 Global Women Health Therapeutics Growth Trends by Regions
2.2.1 Women Health Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Women Health Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Women Health Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Women Health Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Women Health Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Women Health Therapeutics Players by Market Size
3.1.1 Global Top Women Health Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Women Health Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Women Health Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Women Health Therapeutics Market Concentration Ratio
3.2.1 Global Women Health Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Women Health Therapeutics Revenue in 2019
3.3 Women Health Therapeutics Key Players Head office and Area Served
3.4 Key Players Women Health Therapeutics Product Solution and Service
3.5 Date of Enter into Women Health Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Women Health Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Women Health Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Women Health Therapeutics Market Size by Application (2015-2020)
5.2 Global Women Health Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Women Health Therapeutics Market Size (2015-2020)
6.2 Women Health Therapeutics Key Players in North America (2019-2020)
6.3 North America Women Health Therapeutics Market Size by Type (2015-2020)
6.4 North America Women Health Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Women Health Therapeutics Market Size (2015-2020)
7.2 Women Health Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Women Health Therapeutics Market Size by Type (2015-2020)
7.4 Europe Women Health Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Women Health Therapeutics Market Size (2015-2020)
8.2 Women Health Therapeutics Key Players in China (2019-2020)
8.3 China Women Health Therapeutics Market Size by Type (2015-2020)
8.4 China Women Health Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Women Health Therapeutics Market Size (2015-2020)
9.2 Women Health Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Women Health Therapeutics Market Size by Type (2015-2020)
9.4 Japan Women Health Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Women Health Therapeutics Market Size (2015-2020)
10.2 Women Health Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Women Health Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Women Health Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Women Health Therapeutics Market Size (2015-2020)
11.2 Women Health Therapeutics Key Players in India (2019-2020)
11.3 India Women Health Therapeutics Market Size by Type (2015-2020)
11.4 India Women Health Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Women Health Therapeutics Market Size (2015-2020)
12.2 Women Health Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Women Health Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Women Health Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Women Health Therapeutics Introduction
13.1.4 Novartis Revenue in Women Health Therapeutics Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Women Health Therapeutics Introduction
13.2.4 Abbott Revenue in Women Health Therapeutics Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Women Health Therapeutics Introduction
13.3.4 Pfizer Revenue in Women Health Therapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Women Health Therapeutics Introduction
13.4.4 Eli Lilly Revenue in Women Health Therapeutics Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Bayer
13.5.1 Bayer Company Details
13.5.2 Bayer Business Overview
13.5.3 Bayer Women Health Therapeutics Introduction
13.5.4 Bayer Revenue in Women Health Therapeutics Business (2015-2020)
13.5.5 Bayer Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Women Health Therapeutics Introduction
13.6.4 Merck Revenue in Women Health Therapeutics Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Women Health Therapeutics Introduction
13.7.4 Roche Revenue in Women Health Therapeutics Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Novo Nordisk
13.8.1 Novo Nordisk Company Details
13.8.2 Novo Nordisk Business Overview
13.8.3 Novo Nordisk Women Health Therapeutics Introduction
13.8.4 Novo Nordisk Revenue in Women Health Therapeutics Business (2015-2020)
13.8.5 Novo Nordisk Recent Development
13.9 Oasmia
13.9.1 Oasmia Company Details
13.9.2 Oasmia Business Overview
13.9.3 Oasmia Women Health Therapeutics Introduction
13.9.4 Oasmia Revenue in Women Health Therapeutics Business (2015-2020)
13.9.5 Oasmia Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview
13.10.3 Sanofi Women Health Therapeutics Introduction
13.10.4 Sanofi Revenue in Women Health Therapeutics Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Takeda
10.11.1 Takeda Company Details
10.11.2 Takeda Business Overview
10.11.3 Takeda Women Health Therapeutics Introduction
10.11.4 Takeda Revenue in Women Health Therapeutics Business (2015-2020)
10.11.5 Takeda Recent Development
13.12 Allergan
10.12.1 Allergan Company Details
10.12.2 Allergan Business Overview
10.12.3 Allergan Women Health Therapeutics Introduction
10.12.4 Allergan Revenue in Women Health Therapeutics Business (2015-2020)
10.12.5 Allergan Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Women Health Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Women Health Therapeutics Revenue
Table 3. Ranking of Global Top Women Health Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Women Health Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Menopause
Table 6. Key Players of Endometriosis
Table 7. Key Players of Postmenopausal osteoporosis
Table 8. Key Players of Breast cancer
Table 9. Key Players of Polycystic ovary syndrome
Table 10. Key Players of Infertility
Table 11. Key Players of Gynecological cancer
Table 12. Global Women Health Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Women Health Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Women Health Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Women Health Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Women Health Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Women Health Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Women Health Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Women Health Therapeutics Players
Table 23. Global Women Health Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Women Health Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Therapeutics as of 2019)
Table 26. Global Women Health Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Women Health Therapeutics Product Solution and Service
Table 29. Date of Enter into Women Health Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Women Health Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Women Health Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Women Health Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Women Health Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Women Health Therapeutics Market Share (2019-2020)
Table 39. North America Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Women Health Therapeutics Market Share by Type (2015-2020)
Table 41. North America Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Women Health Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Women Health Therapeutics Market Share (2019-2020)
Table 45. Europe Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Women Health Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Women Health Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Women Health Therapeutics Market Share (2019-2020)
Table 51. China Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Women Health Therapeutics Market Share by Type (2015-2020)
Table 53. China Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Women Health Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Women Health Therapeutics Market Share (2019-2020)
Table 57. Japan Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Women Health Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Women Health Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Women Health Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Women Health Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Women Health Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Women Health Therapeutics Market Share (2019-2020)
Table 69. India Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Women Health Therapeutics Market Share by Type (2015-2020)
Table 71. India Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Women Health Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Women Health Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Women Health Therapeutics Market Share (2019-2020)
Table 75. Central & South America Women Health Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Women Health Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Women Health Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Women Health Therapeutics Market Share by Application (2015-2020)
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Product
Table 87. Abbott Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 88. Abbott Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Product
Table 97. Eli Lilly Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 98. Eli Lilly Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. Roche Company Details
Table 110. Roche Business Overview
Table 111. Roche Product
Table 112. Roche Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 113. Roche Recent Development
Table 114. Novo Nordisk Business Overview
Table 115. Novo Nordisk Product
Table 116. Novo Nordisk Company Details
Table 117. Novo Nordisk Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 118. Novo Nordisk Recent Development
Table 119. Oasmia Company Details
Table 120. Oasmia Business Overview
Table 121. Oasmia Product
Table 122. Oasmia Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 123. Oasmia Recent Development
Table 124. Sanofi Company Details
Table 125. Sanofi Business Overview
Table 126. Sanofi Product
Table 127. Sanofi Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 128. Sanofi Recent Development
Table 129. Takeda Company Details
Table 130. Takeda Business Overview
Table 131. Takeda Product
Table 132. Takeda Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 133. Takeda Recent Development
Table 134. Allergan Company Details
Table 135. Allergan Business Overview
Table 136. Allergan Product
Table 137. Allergan Revenue in Women Health Therapeutics Business (2015-2020) (Million US$)
Table 138. Allergan Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women Health Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Menopause Features
Figure 3. Endometriosis Features
Figure 4. Postmenopausal osteoporosis Features
Figure 5. Breast cancer Features
Figure 6. Polycystic ovary syndrome Features
Figure 7. Infertility Features
Figure 8. Gynecological cancer Features
Figure 9. Global Women Health Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Diagnostic and imaging centers Case Studies
Figure 11. Hospitals and clinics Case Studies
Figure 12. Home care Case Studies
Figure 13. Women Health Therapeutics Report Years Considered
Figure 14. Global Women Health Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Women Health Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Women Health Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Women Health Therapeutics Market Share by Players in 2019
Figure 19. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Women Health Therapeutics Revenue in 2019
Figure 21. North America Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Women Health Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
閉経後骨粗鬆症治療薬の世界市場（～2026年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…- 女性健康診断の世界市場（～2026年） Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health. Rising prevalence of infectious disease…
- 女性健康の世界市場（～2026年） Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years. Government and various private organizations are workin…
- 女性健康リハビリテーション製品の世界市場（～2026年） Women rehabilitation products and services (therapy) are used to aid in the recovery of women who have undergone pregnancy (prenatal and post-natal), met with an accident, undergone surgery, or suffering from chronic diseases such as urinary tract infection (UTI), osteoporosis, and lymphedema. Women…
- ペプチド癌治療薬の世界市場（～2026年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…